On Tuesday, December 15, 2009, from 1:30pm – 2:30pm ET, the Lymphoma Research Foundation (LRF) and CancerCare brought together a distinguished panel of researchers and clinicians for a lymphoma teleconference entitled Update on Lymphoma Treatment from the 2009 American Society of Hematology Annual Meeting.

 Archived podcast: Click Here

This program is made possible by unrestricted educational grants to the Lymphoma Research Foundation from Cephalon Oncology, Genentech and Millennium: The Takeda Oncology Company.

Program Faculty

John P. Leonard, MD
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Professor of Medicine, Weill Cornell Medical College, Clinical Director, New York-Cornell Center for Lymphoma and Myeloma, Chief, Lymphoma-Myeloma Service, Associate Director for Clinical Research, Weill Cornell Cancer Center

Oliver W. Press, MD, PhD
Member, Fred Hutchinson Cancer Research Center, Recipient, Dr. Penny E. Petersen Memorial Chair for Lymphoma Research, Professor of Medicine, University of Washington, Co-Chair, NCI Lymphoma Steering Committee

Julie M. Vose, MD
Neumann M. and Mildred E. Harris Professor, Chief, Section of Hematology/Oncology, Professor of Medicine, University of Nebraska Medical Center

Jennifer Mills, LMSW, MPH
National Director, Patient Programs, Lymphoma Research Foundation

Richard Dickens, MSW
Blood Cancers Program Coordinator, CancerCare

Topics Discussed

• Brief Overview of Current Treatments for Lymphoma
• New Research Findings Presented at ASH
• How Research Influences Treatment Options
• Disease-Specific Treatment Updates
• Clinical Trials
• Questions for Our Panel of Experts